` BTTX (Better Therapeutics Inc) vs S&P 500 Comparison - Alpha Spread

BTTX
vs
S&P 500

Over the past 12 months, BTTX has underperformed S&P 500, delivering a return of 0% compared to the S&P 500's +12% growth.

Stocks Performance
BTTX vs S&P 500

Loading
BTTX
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
BTTX vs S&P 500

Loading
BTTX
S&P 500
Difference
www.alphaspread.com

Performance By Year
BTTX vs S&P 500

Loading
BTTX
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Better Therapeutics Inc vs Peers

S&P 500
BTTX
VEEV
PME
2413
DOCS
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Better Therapeutics Inc
Glance View

Market Cap
5k USD
Industry
Health Care

Better Therapeutics, Inc. develops a software-based prescription digital therapeutics for treating diabetes, heart disease, and other cardiometabolic conditions. The company is headquartered in New York City, New York and currently employs 44 full-time employees. The company went IPO on 2021-01-08. The firm creates treatments to reverse the progression of disease, improve quality of life, and inform clinical decisions. The company builds prescription digital therapeutics that deliver a new kind of behavioral therapy and creating feedback mechanisms using remotely-monitored and patient-generated data. Its clinical development pipeline includes BT-001, BT-002, BT-003, BT-004 and BT-005. The company is evaluating BT-001 in a pivotal study as a prescribed treatment used under physician supervision for people with uncontrolled type 2 diabetes. The firm develops Nutritional Cognitive Behavioral Therapy (Nutritional CBT), which is a novel form of behavioral therapy under development for the treatment of patients with type 2 diabetes and other cardiometabolic diseases.

BTTX Intrinsic Value
Not Available
Back to Top